<collection><source>PMC</source><date>20201214</date><key>pmc.key</key><document><id>32173</id><infon key="license">NO-CC CODE</infon><passage><infon key="article-id_doi">10.1186/1472-6904-1-2</infon><infon key="article-id_pmc">32173</infon><infon key="article-id_pmid">11339881</infon><infon key="article-id_publisher-id">1472-6904-1-2</infon><infon key="fpage">2</infon><infon key="journal-title">BMC Clinical Pharmacology</infon><infon key="lpage">2</infon><infon key="name_0">surname:Mieczkowski;given-names:Tom</infon><infon key="name_1">surname:Tsatsakis;given-names:Aristidis M</infon><infon key="name_2">surname:Kruger;given-names:Michael</infon><infon key="name_3">surname:Psillakis;given-names:Thanasis</infon><infon key="section_type">TITLE</infon><infon key="type">front</infon><infon key="volume">1</infon><infon key="year">2001</infon><offset>0</offset><text>The concentration of three anti-seizure medications in hair: the effects of hair color, controlling for dose and age</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>117</offset><text>What is the background on this?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>128</offset><text>The paper analyzes the correlation between the quantity of three anti-seizure drugs in hair and the color of the analyzed hair, while accounting for the effects of dose, duration, and patient age. 140 clinical patients were evaluated using carbamazepine (40 patients), valproic acid (80 patients) and phenytoin (60 patients). The analysis employs a covariance model that considers hair color, hair assay results, qualitative categorical independent variables, do, dose time, AND no negative variables as null</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1075</offset><text>What are the outcomes?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1083</offset><text>The study shows that the categorical independent variable and the other covariates are insufficient to determine whether the dos and don't correlate significantly with any of the categories of hair color.</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract_title_1</infon><offset>1283</offset><text>What is the conclusion?</text></passage><passage><infon key="section_type">ABSTRACT</infon><infon key="type">abstract</infon><offset>1294</offset><text>The data suggests that hair color is not influenced by carbamazepine concentration and therefore does not appear to be affected. Valproic acid concentration may be slightly linked to hair colour, which could be impacted by age. There is also a significant, moderate relationship between phenytoin concentrations and hair dyeing, with darker hair having higher concentration values than those with lighter hair.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">title_1</infon><offset>1702</offset><text>This article is an introduction to the study of hair color. The author</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>1713</offset><text>Human hair has been used extensively in a range of settings to test for the presence of ingested chemical substances, including being used to determine the level of exposure to heavy metals post-mortem or during living hours. Other areas have seen significant progress in recovering illicit psychoactive substances and their metabolites from human hair.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>2925</offset><text>The enhanced ability to detect and quantify routine drug use enables hair analysis to serve as a valuable diagnostic tool in clinical trials of anti-eizure drugs.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>3889</offset><text>There is a debate about whether hair analysis can accurately measure the presence or absence of compounds, with some suggesting that it cannot be applied to all patients.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>5072</offset><text>There is a lack of clarity regarding the extensive biovariability that can be observed among individuals given the same medication. Clinicians acknowledge that multiple factors can affect drug concentrations in an analytic matrix, and they recognize that hair samples can provide valuable information about possible effects caused by color differences, cosmetic treatments, or hair hygiene practices. However, there are still concerns about whether systematic influences can influence drug dosages and compliance with self-reported drugs.</text></passage><passage><infon key="section_type">INTRO</infon><infon key="type">paragraph</infon><offset>6710</offset><text>A common flaw in the analysis of hair assay data is the inadequacy of the statistical models used to assess experimental information, which can lead to false claims or conclusions based on unsupported statistical data. In some cases, the analyses of experimental hair analysis data reveal that these conclusions are far from correct. Nor have any available sophisticated and sensitive statistical techniques been applied to multivariate phenomena. Despite this, there is a general consensus that the relationship between dose and assync is likely to be mediated by complex series of intervening events.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">title_1</infon><offset>7754</offset><text>Materials and Methods</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>7776</offset><text>The analysis is based upon the concentrations obtained from scalp hair collected by cutting hair from the posterior vertex of the head. Each sample consisted of approximately 200 mg of hair. Each sample was sectioned into 2-cm segments and each segment was analyzed by FPIA and HPLC methods for CBZ and PHT and by FPIA for VPA. The number of segments for each patient varied, since it was dependent of length of hair available from each individual. Most patients have five segments and no patient provided less than two segments. The concentrations used for each case are the mean values for all available segments for that patient. HPLC values are used in the analysis of CBZ and PHT, FPIA values are used in the analysis of VPA. As well, serum assay values are provided for each patient. The serum assay typology varied, including multiple methods to assay serum for some drugs. For CBZ serum was assayed by both FPIA and GC/MS, for VPA by FPIA, and for PHT by FPIA and HPLC. Bloods were drawn from patients in the morning by their attending physician. In a few cases there were multiple bloods drawn. In such cases the mean values for the serum levels are represented in the tables. Hair color assignments were based upon observation by the attending physician, questioning of the patient and in cases of ambiguity by consultation among the field research staff, the attending physician, and the patient.</text></passage><passage><infon key="section_type">METHODS</infon><infon key="type">paragraph</infon><offset>9184</offset><text>Since this is a secondary analysis of data, only a synopsis of technical procedures is presented here. Details of the instrumentation, including calibration and standardization, and elaboration of the analysis techniques are described in detail elsewhere and are not repeated here. The general approach was as follows: hair samples were dissolved in a strong base (NaOH) and the dissolved material was subjected to solvent extraction. Hair samples were segmented in 2-cm sections, and 30-50 mg of hair from each segment was added to 3 ml of 1 N NaOH solution. The solution was solvent extracted with diethyl ether, centrifuged, and the supernatant evaporated. The remnant residue was dissolved in saline and subjected to analysis.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_1</infon><offset>9915</offset><text>Result and Discussion</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>9937</offset><text>In this study we report on the relation between the concentration of three widely used anti-epileptic medications, CBZ, PHT, and VPA, in hair and the correlation between dose and concentration. In addition, we explore the relationship between concentration and hair color, between assay variability and age, and the interaction effects between these variables. We also assess the degree to which the data meet critical assumptions regarding the normality, distribution shape, and variance homogeneity. The statistical method employed is an analysis of covariance, in which each drug employs a model incorporating the concentration of the target drug in hair as the dependent variable, the hair color categorization as the independent variable, and dosage, duration of dose, and age as model covariates.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>10740</offset><text>Carbamazepine (CBZ)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>10760</offset><text>The data set consists of 40 subjects (18 females, 22 males) who were on a regimen of CBZ for the control of seizures. The mean of age of this group is 30.3 years, s.d. 18.6 (median 25.0). Age skewness (.651) and kurtosis (-.506) are within normal bounds. The mean length of time (duration) of the dose regimen for this group was 16.95 months (s.d. 8.59) with a range of from 2 to 24 months. The dosage values (in mg/day) ranged from 200 to 1,000 with a mean dose of 525 mg/day (s.d. 208.47, median 450). For both duration of regimen and daily dosage the skewness and kurtosis values are within normal range (&lt;2).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>11373</offset><text>General Dose/Assay Relationship</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>11405</offset><text>The data for the dose assay relationship includes concentration in the plasma serum, which was determined by both FPIA and GC, and concentration in the hair, which was determined by both FPIA and HPLC. For hair assays the values are in micrograms per gram of hair, and for serum the values are in micrograms per milliliter of plasma. The findings show that there was no significant dose/assay relationship for the serum specimens with either analytic technique, and that there was a significant dose/assay relationship for hair specimens by both analytic techniques. The results are shown in Table 1.</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>12006</offset><text>Mean Concentration Values and Correlation Coefficients for Dose/Assay Relationship for Hair and Plasma, CBZ</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;CBZ&lt;/td&gt;&lt;td align="center"&gt;HPLC Hair&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;Correlation&lt;/td&gt;&lt;td align="center"&gt;FPIA&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;Correlation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Specimen&lt;/td&gt;&lt;td align="center"&gt;Dose&lt;/td&gt;&lt;td align="center"&gt;Concentration&lt;/td&gt;&lt;td align="center"&gt;S.D.&lt;/td&gt;&lt;td align="center"&gt;Coefficient&lt;/td&gt;&lt;td align="center"&gt;Concentration&lt;/td&gt;&lt;td align="center"&gt;S.D.&lt;/td&gt;&lt;td align="center"&gt;Coefficient&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;(mg/day)&lt;/td&gt;&lt;td align="center"&gt;(mcg/g)&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;(r)&lt;/td&gt;&lt;td align="center"&gt;(mcg/g)&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;(r)&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Hair&lt;/td&gt;&lt;td align="center"&gt;525&lt;/td&gt;&lt;td align="center"&gt;18.20&lt;/td&gt;&lt;td align="center"&gt;6.02&lt;/td&gt;&lt;td align="center"&gt;0.476&lt;sup&gt;**&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;21.12&lt;/td&gt;&lt;td align="center"&gt;7.01&lt;/td&gt;&lt;td align="center"&gt;0.459&lt;sup&gt;**&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="8"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;CBZ&lt;/td&gt;&lt;td align="center"&gt;GC Serum&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;Correlation&lt;/td&gt;&lt;td align="center"&gt;FPIA Serum&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;Correlation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Specimen&lt;/td&gt;&lt;td align="center"&gt;Dose&lt;/td&gt;&lt;td align="center"&gt;Concentration&lt;/td&gt;&lt;td align="center"&gt;S.D.&lt;/td&gt;&lt;td align="center"&gt;Coefficient&lt;/td&gt;&lt;td align="center"&gt;Concentration&lt;/td&gt;&lt;td align="center"&gt;S.D.&lt;/td&gt;&lt;td align="center"&gt;Coefficient&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;(mg/day)&lt;/td&gt;&lt;td align="center"&gt;(mcg/g)&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;(r)&lt;/td&gt;&lt;td align="center"&gt;(mcg/g)&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;(r)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="8"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Serum&lt;/td&gt;&lt;td align="center"&gt;525&lt;/td&gt;&lt;td align="center"&gt;7.37&lt;/td&gt;&lt;td align="center"&gt;1.44&lt;/td&gt;&lt;td align="center"&gt;.067&lt;/td&gt;&lt;td align="center"&gt;7.62&lt;/td&gt;&lt;td align="center"&gt;1.50&lt;/td&gt;&lt;td align="center"&gt;.143&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>12114</offset><text>	CBZ	HPLC Hair		Correlation	FPIA		Correlation	 	Specimen	Dose	Concentration	S.D.	Coefficient	Concentration	S.D.	Coefficient	 		(mg/day)	(mcg/g)		(r)	(mcg/g)		(r)	 	Hair	525	18.20	6.02	0.476**	21.12	7.01	0.459**	 		 		CBZ	GC Serum		Correlation	FPIA Serum		Correlation	 	Specimen	Dose	Concentration	S.D.	Coefficient	Concentration	S.D.	Coefficient	 		(mg/day)	(mcg/g)		(r)	(mcg/g)		(r)	 		 	Serum	525	7.37	1.44	.067	7.62	1.50	.143	 	</text></passage><passage><infon key="file">T1.xml</infon><infon key="id">T1</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>12545</offset><text>** significant @.01, two-tailed</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>12577</offset><text>Hair Color</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>12588</offset><text>It has been a source of controversy in the interpretation of hair assays whether or not hair color is a critical factor in the binding of materials in hair. It has previously reported that CBZ does not appear to have a significant "color effect" (i.e., that darker hair shows significantly higher concentrations of CBZ than light hair). We examine this finding using the current data. There are five color categorizations of hair represented among the 40 subjects. The distribution of hair color and the mean concentration of CBZ for each color are shown in Table 2. The concentration values are in micrograms/gram as measured by HPLC.</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>13224</offset><text>Mean Concentration of CBZ by Hair Color</text></passage><passage><infon key="file">T2.xml</infon><infon key="id">T2</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Number of&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean CBZ&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Standard&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Subjects&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Concentration&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Deviation&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;15&lt;/td&gt;&lt;td align="center"&gt;17.59&lt;/td&gt;&lt;td align="center"&gt;5.95&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;15&lt;/td&gt;&lt;td align="center"&gt;18.05&lt;/td&gt;&lt;td align="center"&gt;5.74&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;24.23&lt;/td&gt;&lt;td align="center"&gt;6.22&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;13.58&lt;/td&gt;&lt;td align="center"&gt;3.27&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Dyed&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;19.97&lt;/td&gt;&lt;td align="center"&gt;7.39&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="4"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Overall Mean&lt;/td&gt;&lt;td align="center"&gt;40&lt;/td&gt;&lt;td align="center"&gt;18.20&lt;/td&gt;&lt;td align="center"&gt;6.02&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>13264</offset><text>Hair Color	Number of	Mean CBZ	Standard	 		Subjects	Concentration	Deviation	 	Black	15	17.59	5.95	 	Brown	15	18.05	5.74	 	Blond	3	24.23	6.22	 	Gray	3	13.58	3.27	 	Dyed	4	19.97	7.39	 		 	Overall Mean	40	18.20	6.02	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13479</offset><text>An analysis of variance for this table fails to show a significant relationship between CBZ mean value and hair color (F = 1.374, p= .263). The Levene Test for equality of error variances indicates that the homogeneity of variance assumption is met (Levene F = .303, p = .874). The K-S and Shapiro-Wilk tests for normality are consistent with a normal distribution and a normal Q-Q plot of CBZ concentration in hair shows a good approximation of normality.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>13936</offset><text>Hair Color/Dose Relationship</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>13965</offset><text>Another factor worth consideration is the possible interaction effect between hair color and dose. The dose values and hair color categories can be a shown as a matrix array as in Table 3.</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>14154</offset><text>Frequency Distribution of CBZ Dosage by Hair Color</text></passage><passage><infon key="file">T3.xml</infon><infon key="id">T3</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;CBZ&lt;/bold&gt;&lt;/td&gt;&lt;td align="center" colspan="6"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td colspan="6"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Dose&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;Dyed&lt;/td&gt;&lt;td align="center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;(mg/day)&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;200&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;300&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;400&lt;/td&gt;&lt;td align="center"&gt;5&lt;/td&gt;&lt;td align="center"&gt;9&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;15&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;500&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;600&lt;/td&gt;&lt;td align="center"&gt;7&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;11&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;800&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;1000&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Total&lt;/td&gt;&lt;td align="center"&gt;15&lt;/td&gt;&lt;td align="center"&gt;15&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;40&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>14205</offset><text>CBZ	Hair Color	 			 	Dose							 		Black	Brown	Blond	Gray	Dyed	Total	 	(mg/day)							 	200		2			1	3	 	300	1			1		2	 	400	5	9		1		15	 	500		1		1		2	 	600	7	1	2		1	11	 	800	1	2	1			4	 	1000	1				2	3	 		 	Total	15	15	3	3	4	40	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>14432</offset><text>Table 3 is a crosstabulation showing the distribution of dosage values by hair color. Review of the cell distributions shows a concentration of higher dose regimens to cluster towards the lower left, indicating the possibility that persons with black hair may more likely to be on higher doses of CBZ and persons with lighter hair may be more likely to receive lower doses. The GLM covariance model is based on the mean hair assay outcomes (HPLC). The analysis of covariance (ANCOVA) allows for the comparison of quantitative dependent and qualitative independent variable while simultaneously controlling for a number of quantitative variables or covariates. In this analysis, the dependent variable is the mean concentration for the hair analysis, the independent qualitative variable is the hair color categorization, and the covariates are duration of dose (in months), dose (in mgs. per 24 hours), and patient age (in years). The outcome of this model is shown in Table 4.</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>15410</offset><text>General Linear Model, Analysis of Covariance, Hair Assay Outcome by Color, Dose, Dose Duration, and Age, CBZ</text></passage><passage><infon key="file">T4.xml</infon><infon key="id">T4</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;Source&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Type III Sum&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;df&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;F&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Sig.&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Eta&lt;sup&gt;2&lt;/sup&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;of Squares&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Square&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Model&lt;/td&gt;&lt;td align="center"&gt;428.88&lt;/td&gt;&lt;td align="center"&gt;7&lt;/td&gt;&lt;td align="center"&gt;61.27&lt;/td&gt;&lt;td align="center"&gt;1.995&lt;/td&gt;&lt;td align="center"&gt;.087&lt;/td&gt;&lt;td align="center"&gt;.304&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Intercept&lt;/td&gt;&lt;td align="center"&gt;346.37&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;346.37&lt;/td&gt;&lt;td align="center"&gt;11.281&lt;/td&gt;&lt;td align="center"&gt;.002&lt;/td&gt;&lt;td align="center"&gt;.261&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;CBZDOSE&lt;/td&gt;&lt;td align="center"&gt;154.13&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;346.37&lt;/td&gt;&lt;td align="center"&gt;11.281&lt;/td&gt;&lt;td align="center"&gt;.002&lt;/td&gt;&lt;td align="center"&gt;.136&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;DOSEDUR&lt;/td&gt;&lt;td align="center"&gt;2.89&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;2.89&lt;/td&gt;&lt;td align="center"&gt;.094&lt;/td&gt;&lt;td align="center"&gt;.761&lt;/td&gt;&lt;td align="center"&gt;.003&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;AGE&lt;/td&gt;&lt;td align="center"&gt;.636&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;.636&lt;/td&gt;&lt;td align="center"&gt;.021&lt;/td&gt;&lt;td align="center"&gt;.886&lt;/td&gt;&lt;td align="center"&gt;.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;COLOR&lt;/td&gt;&lt;td align="center"&gt;83.78&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;20.95&lt;/td&gt;&lt;td align="center"&gt;.682&lt;/td&gt;&lt;td align="center"&gt;.609&lt;/td&gt;&lt;td align="center"&gt;.079&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Error&lt;/td&gt;&lt;td align="center"&gt;982.57&lt;/td&gt;&lt;td align="center"&gt;32&lt;/td&gt;&lt;td align="center"&gt;30.71&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Total&lt;/td&gt;&lt;td align="center"&gt;14658.77&lt;/td&gt;&lt;td align="center"&gt;40&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Total&lt;/td&gt;&lt;td align="center"&gt;1411.45&lt;/td&gt;&lt;td align="center"&gt;39&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>15519</offset><text>Source	Type III Sum	df	Mean	F	Sig.	Eta2	 		of Squares		Square				 	Corrected Model	428.88	7	61.27	1.995	.087	.304	 	Intercept	346.37	1	346.37	11.281	.002	.261	 	CBZDOSE	154.13	1	346.37	11.281	.002	.136	 	DOSEDUR	2.89	1	2.89	.094	.761	.003	 	AGE	.636	1	.636	.021	.886	.001	 	COLOR	83.78	4	20.95	.682	.609	.079	 		 	Error	982.57	32	30.71				 		 	Total	14658.77	40					 		 	Corrected Total	1411.45	39					 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>15924</offset><text>Table 4 reveals that there is a relation between mean hair concentration and dose (F = 5.020, p = .032, eta2 = .136, shaded row) while the relationship between hair assay result and color is not significant (F = .682, p = .609, eta2 = .079). Thus it is reasonable to conclude that differential hair assay outcomes for CBZ are not color dependent, but are significantly related to dose regimens.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>16319</offset><text>Valproic Acid (VPA)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>16339</offset><text>The VPA data set consists of 40 subjects (25 females, 15 males) who were on a regimen of VPA for the control of seizures. The mean of age of this group is 23.25 years, s.d. 19.15 (median 18.0). Age skewness is 1.73 and kurtosis is 3.35. The skewness is somewhat outside of normal bounds (ratio 4.6), the kurtosis (ratio 4.5) indicates a peaked distribution. Neither ratio is, however, extreme. The mean length of time (duration) of the dose regimen for this group was 16.275 months (s.d. 8.51) with a range of 23 months. The dosage values (in mg/day) ranged from 200 to 3000 mg/day with a mean dose of 822.5 mg/day (s.d. 558.6, median 600). For both duration of regimen and daily dosage the skewness and kurtosis values are within normal range (&lt;2).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>17089</offset><text>General Dose/Assay Relationship</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>17121</offset><text>The data for the VPA dose assay relationship includes concentration in the plasma serum, which was determined by FPIA, and concentration in the hair, which was determined by FPIA. For hair assays the values are in micrograms per gram of hair, and for serum the values are in micrograms per milliliter of plasma. The findings show that there was no significant dose/assay relationship for the VPA serum specimens, and that there was a significant correlation dose/assay relationship for VPA hair specimens. The results are shown in Table 5.</text></passage><passage><infon key="file">T5.xml</infon><infon key="id">T5</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>17661</offset><text>Mean Concentration Values and Correlation Coefficients for Dose/Assay Relationship for Hair and Plasma, VPA</text></passage><passage><infon key="file">T5.xml</infon><infon key="id">T5</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;VPA&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;FPIA Mean&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Correlation&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Specimen&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Concentration&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;S.D.&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Coefficient&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Dose&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;(mcg/g)&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;(r)&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;(mg/day)&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Hair&lt;/td&gt;&lt;td align="center"&gt;822.5&lt;/td&gt;&lt;td align="center"&gt;8.22&lt;/td&gt;&lt;td align="center"&gt;3.37&lt;/td&gt;&lt;td align="center"&gt;.717&lt;sup&gt;**&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;VPA&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;FPIA Mean&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Correlation&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Specimen&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Concentration&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;S.D.&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Coefficient&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Dose&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;(mcg/ml)&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;(r)&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;(mg/day)&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Serum&lt;/td&gt;&lt;td align="center"&gt;822.5&lt;/td&gt;&lt;td align="center"&gt;60.8&lt;/td&gt;&lt;td align="center"&gt;20.74&lt;/td&gt;&lt;td align="center"&gt;.128&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>17769</offset><text>	VPA	FPIA Mean		Correlation	 	Specimen	Mean	Concentration	S.D.	Coefficient	 		Dose	(mcg/g)		(r)	 		(mg/day)				 	Hair	822.5	8.22	3.37	.717**	 		 		VPA	FPIA Mean		Correlation	 	Specimen	Mean	Concentration	S.D.	Coefficient	 		Dose	(mcg/ml)		(r)	 		(mg/day)				 		 	Serum	822.5	60.8	20.74	.128	 	</text></passage><passage><infon key="file">T5.xml</infon><infon key="id">T5</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>18063</offset><text>** significant @.01, two-tailed</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>18095</offset><text>Hair Color</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18106</offset><text>As with CBZ, we will examine the potential for a "color effect" associated with the reported concentrations of recovered VPA. The color categorizations are identical to those used for CBZ. Table 6 reports the mean concentration of VPA by hair color category. There are no dyed specimens so four color categories are used in this analysis.</text></passage><passage><infon key="file">T6.xml</infon><infon key="id">T6</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>18445</offset><text>Mean Concentration of VPA by Hair Color</text></passage><passage><infon key="file">T6.xml</infon><infon key="id">T6</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Number of&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean VPA&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Standard&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Subjects&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Concentration&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Deviation&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;17&lt;/td&gt;&lt;td align="center"&gt;9.65&lt;/td&gt;&lt;td align="center"&gt;3.39&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;17&lt;/td&gt;&lt;td align="center"&gt;7.58&lt;/td&gt;&lt;td align="center"&gt;3.30&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;5.80&lt;/td&gt;&lt;td align="center"&gt;1.36&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;6.08&lt;/td&gt;&lt;td align="center"&gt;2.12&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="4"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Overall Mean&lt;/td&gt;&lt;td align="center"&gt;40&lt;/td&gt;&lt;td align="center"&gt;8.22&lt;/td&gt;&lt;td align="center"&gt;3.37&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>18485</offset><text>Hair Color	Number of	Mean VPA	Standard	 		Subjects	Concentration	Deviation	 	Black	17	9.65	3.39	 	Brown	17	7.58	3.30	 	Blond	3	5.80	1.36	 	Gray	3	6.08	2.12	 		 	Overall Mean	40	8.22	3.37	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>18675</offset><text>An analysis of variance for Table 6 fails to show a significant relationship between VPA mean values and hair color (F = 2.354, p = .088). The Levene Test for equality of error variances indicates that the homogeneity of variances assumptions is met (Levene F = 2.491, p = .076). The K-S test for normality is consistent with a normal distribution and a normal Q-Q plot of VPA concentration in hair shows a good approximation of normality.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>19115</offset><text>Hair Color Relationship</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19139</offset><text>As with CBZ, we now consider the possible interaction of hair color, dose, and recovered VPA from hair. Table 7 presents the frequency distribution of dose by hair color.</text></passage><passage><infon key="file">T7.xml</infon><infon key="id">T7</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>19310</offset><text>Frequency Distribution of VPA Dosage by Hair Color</text></passage><passage><infon key="file">T7.xml</infon><infon key="id">T7</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;VPA Dose&lt;/bold&gt;&lt;/td&gt;&lt;td align="center" colspan="6"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td colspan="5"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;(mg/day)&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;Total&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;200&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;300&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;400&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;500&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;600&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;7&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;700&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;800&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;900&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;1000&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;5&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;1500&lt;/td&gt;&lt;td align="center"&gt;7&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;8&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;3000&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Total&lt;/td&gt;&lt;td align="center"&gt;17&lt;/td&gt;&lt;td align="center"&gt;17&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;40&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>19361</offset><text>VPA Dose	Hair Color	 			 	(mg/day)						 		Black	Brown	Blond	Gray	Total	 	200		1			1	 	300	2	3		1	6	 	400	1	3		1	5	 	500	3				3	 	600	3	3	1		7	 	700		1			1	 	800			2		2	 	900		1			1	 	1000	1	3		1	5	 	1500	7	1			8	 	3000		1			1	 		 	Total	17	17	3	3	40	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>19615</offset><text>Visual inspection of the Table 7 is consistent with the impression that there may be a slight skewing of higher dosage regimens towards dark-haired subjects. We subject this data to an ANCOVA. As previously, we treat mean concentration as the dependent term, color as the independent qualitative term, and dose duration, 24-hour dose value and age as the covariates. The outcome for this model is reported in Table 8. The Levene statistic shows the variance homogeneity criteria are met, and analysis of the normality of the distribution of the mean hair values shows acceptable conformity with normality assumptions.</text></passage><passage><infon key="file">T8.xml</infon><infon key="id">T8</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>20233</offset><text>General Linear Model, Analysis of Covariance, Hair Assay Outcome by Color, Dose, Dose Duration, and Age, VPA.</text></passage><passage><infon key="file">T8.xml</infon><infon key="id">T8</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;Source&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Type III Sum&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;df&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;F&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Sig.&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Eta&lt;sup&gt;2&lt;/sup&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;of Squares&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Square&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Model&lt;/td&gt;&lt;td align="center"&gt;299.12&lt;/td&gt;&lt;td align="center"&gt;6&lt;/td&gt;&lt;td align="center"&gt;49.85&lt;/td&gt;&lt;td align="center"&gt;11.38&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;td align="center"&gt;.674&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Intercept&lt;/td&gt;&lt;td align="center"&gt;10.52&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;10.52&lt;/td&gt;&lt;td align="center"&gt;2.40&lt;/td&gt;&lt;td align="center"&gt;.131&lt;/td&gt;&lt;td align="center"&gt;.068&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;VPADOSE&lt;/td&gt;&lt;td align="center"&gt;61.03&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;61.03&lt;/td&gt;&lt;td align="center"&gt;13.93&lt;/td&gt;&lt;td align="center"&gt;.001&lt;/td&gt;&lt;td align="center"&gt;.297&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;DOSEDUR&lt;/td&gt;&lt;td align="center"&gt;11.55&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;11.55&lt;/td&gt;&lt;td align="center"&gt;2.64&lt;/td&gt;&lt;td align="center"&gt;.114&lt;/td&gt;&lt;td align="center"&gt;.074&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;AGE&lt;/td&gt;&lt;td align="center"&gt;23.35&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;23.35&lt;/td&gt;&lt;td align="center"&gt;5.33&lt;/td&gt;&lt;td align="center"&gt;.027&lt;/td&gt;&lt;td align="center"&gt;.139&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;COLOR&lt;/td&gt;&lt;td align="center"&gt;51.16&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;17.05&lt;/td&gt;&lt;td align="center"&gt;3.892&lt;/td&gt;&lt;td align="center"&gt;.017&lt;/td&gt;&lt;td align="center"&gt;.264&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Error&lt;/td&gt;&lt;td align="center"&gt;144.59&lt;/td&gt;&lt;td align="center"&gt;33&lt;/td&gt;&lt;td align="center"&gt;4.38&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Total&lt;/td&gt;&lt;td align="center"&gt;3143.34&lt;/td&gt;&lt;td align="center"&gt;40&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Total&lt;/td&gt;&lt;td align="center"&gt;443.71&lt;/td&gt;&lt;td align="center"&gt;39&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>20343</offset><text>Source	Type III Sum	df	Mean	F	Sig.	Eta2	 		of Squares		Square				 	Corrected Model	299.12	6	49.85	11.38	.000	.674	 	Intercept	10.52	1	10.52	2.40	.131	.068	 	VPADOSE	61.03	1	61.03	13.93	.001	.297	 	DOSEDUR	11.55	1	11.55	2.64	.114	.074	 	AGE	23.35	1	23.35	5.33	.027	.139	 	COLOR	51.16	3	17.05	3.892	.017	.264	 		 	Error	144.59	33	4.38				 		 	Total	3143.34	40					 		 	Corrected Total	443.71	39					 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>20743</offset><text>Table 8 demonstrates that the relationships between dose, age, and hair color are all significant (shaded rows), while duration of dose regimen is not. Furthermore the eta2 values, which are interpretable as a measure of the percentage of the explainable variance, show similar contributions between color and dose, and a lesser contribution due to age. Table 9 reports these contrasts using Bonferroni's criteria.</text></passage><passage><infon key="file">T9.xml</infon><infon key="id">T9</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>21158</offset><text>Pairwise Comparisons, Hair Color Categories by Mean VPA Concentration</text></passage><passage><infon key="file">T9.xml</infon><infon key="id">T9</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Std.&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Sig.&lt;sup&gt;a&lt;/sup&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;(I)&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;(J)&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Difference&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Error&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;(I-J)&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;1.811&lt;/td&gt;&lt;td align="center"&gt;.758&lt;/td&gt;&lt;td align="center"&gt;.135&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;3.584&lt;/td&gt;&lt;td align="center"&gt;1.368&lt;/td&gt;&lt;td align="center"&gt;.078&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;6.457&lt;/td&gt;&lt;td align="center"&gt;2.344&lt;/td&gt;&lt;td align="center"&gt;.056&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;-1.811&lt;/td&gt;&lt;td align="center"&gt;.759&lt;/td&gt;&lt;td align="center"&gt;.135&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;1.772&lt;/td&gt;&lt;td align="center"&gt;1.345&lt;/td&gt;&lt;td align="center"&gt;1.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;4.646&lt;/td&gt;&lt;td align="center"&gt;2.209&lt;/td&gt;&lt;td align="center"&gt;.258&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;-3.584&lt;/td&gt;&lt;td align="center"&gt;1.368&lt;/td&gt;&lt;td align="center"&gt;.078&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;-1.772&lt;/td&gt;&lt;td align="center"&gt;1.345&lt;/td&gt;&lt;td align="center"&gt;1.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;2.873&lt;/td&gt;&lt;td align="center"&gt;2.422&lt;/td&gt;&lt;td align="center"&gt;1.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;-6.457&lt;/td&gt;&lt;td align="center"&gt;2.344&lt;/td&gt;&lt;td align="center"&gt;.056&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;-4.646&lt;/td&gt;&lt;td align="center"&gt;2.209&lt;/td&gt;&lt;td align="center"&gt;.258&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;-2.873&lt;/td&gt;&lt;td align="center"&gt;2.422&lt;/td&gt;&lt;td align="center"&gt;1.000&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>21228</offset><text>Hair Color	Hair Color	Mean	Std.	Sig.a	 	(I)	(J)	Difference	Error		 			(I-J)			 	Black	Brown	1.811	.758	.135	 		Blond	3.584	1.368	.078	 		Gray	6.457	2.344	.056	 	Brown	Black	-1.811	.759	.135	 		Blond	1.772	1.345	1.000	 		Gray	4.646	2.209	.258	 	Blond	Black	-3.584	1.368	.078	 		Brown	-1.772	1.345	1.000	 		Gray	2.873	2.422	1.000	 	Gray	Black	-6.457	2.344	.056	 		Brown	-4.646	2.209	.258	 		Blond	-2.873	2.422	1.000	 	</text></passage><passage><infon key="file">T9.xml</infon><infon key="id">T9</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>21645</offset><text>a Bonferroni adjustment for multiple comparisons</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>21694</offset><text>The Bonferroni criteria contrasts indicate that specific pair comparisons do not yield a significant difference, although the contrasts for black/gray and black/blond are approaching significance. Doing the pairs comparisons using Sidak criteria yields the same results. Both of these confidence interval criteria are conservative but the Bonferroni criteria are preferred on the basis that there is a relatively small number of comparison pairs.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>22141</offset><text>An additional issue of importance is the potential complex interaction between dose, age, and color categorization. First, the data demonstrate a difference in mean dose value by age, although those differences are not significant for VPA (the correlation for dose and age is r = .265, p = .098). Furthermore, the covariance model can be used to generate model regression-derived mean estimates (adjusted for age and dose) that can be compared to the observed values. Both the analytic values and the estimated values are shown in Table 10.</text></passage><passage><infon key="file">T10.xml</infon><infon key="id">T10</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>22682</offset><text>Mean Concentration Values and Model-Estimated Mean Values, VPA</text></passage><passage><infon key="file">T10.xml</infon><infon key="id">T10</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Estimated Means&lt;sup&gt;1&lt;/sup&gt;,&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;(N)&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Concentration&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;VPA (S.E.)&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;VPA (S.D.)&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Black (17)&lt;/td&gt;&lt;td align="center"&gt;9.65 (3.39)&lt;/td&gt;&lt;td align="center"&gt;9.74 (.572)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Brown (17)&lt;/td&gt;&lt;td align="center"&gt;7.58 (3.30)&lt;/td&gt;&lt;td align="center"&gt;7.93 (.525)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Blond (3)&lt;/td&gt;&lt;td align="center"&gt;5.81 (1.36)&lt;/td&gt;&lt;td align="center"&gt;6.15 (1.24)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Gray (3)&lt;/td&gt;&lt;td align="center"&gt;6.08 (2.12)&lt;/td&gt;&lt;td align="center"&gt;3.64 (2.09)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>22745</offset><text>Hair Color	Mean	Estimated Means1,	 	(N)	Concentration	VPA (S.E.)	 		VPA (S.D.)		 	Black (17)	9.65 (3.39)	9.74 (.572)	 	Brown (17)	7.58 (3.30)	7.93 (.525)	 	Blond (3)	5.81 (1.36)	6.15 (1.24)	 	Gray (3)	6.08 (2.12)	3.64 (2.09)	 	</text></passage><passage><infon key="file">T10.xml</infon><infon key="id">T10</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>22973</offset><text>1Evaluated at model covariates: VPA dose (mg/24hr) = 822.5, Age = 23.25</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>23045</offset><text>Comparison of the observed mean values and the model-estimated mean values shows that the model is relatively efficient for all color categorizations except gray hair, where the observed values are nearly twice the value of the estimated values. Since age and gray hair are collinear in the data set Table 10, it is possible that the age/color account for this departure. Regression evaluation of the color/age collinearity for either dose or mean concentration is consistent with this effect (eigenvalue, age = .228, eigenvalue, color = .081). Small eigenvalues are consistent with collinearity between the covariate factors, and thus these values are indicative of an age/color collinear condition.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>23746</offset><text>To further examine this effect, we produce a final covariance model for VPA with color categorization as the independent factor and dose as the covariate. The results of this model are presented in Table 11.</text></passage><passage><infon key="file">T11.xml</infon><infon key="id">T11</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>23954</offset><text>General Linear Model, Analysis of Covariance, Hair Assay Outcome by Color and Dose VPA</text></passage><passage><infon key="file">T11.xml</infon><infon key="id">T11</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;Source&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Type III Sum&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;df&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;F&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Sig.&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Eta&lt;sup&gt;2&lt;/sup&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;of Squares&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Square&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Model&lt;/td&gt;&lt;td align="center"&gt;263.71&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;65.928&lt;/td&gt;&lt;td align="center"&gt;12.82&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;td align="center"&gt;.594&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Intercept&lt;/td&gt;&lt;td align="center"&gt;185.62&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;185.62&lt;/td&gt;&lt;td align="center"&gt;36.09&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;td align="center"&gt;.508&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;VPADOSE&lt;/td&gt;&lt;td align="center"&gt;190.93&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;190.93&lt;/td&gt;&lt;td align="center"&gt;37.13&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;td align="center"&gt;.515&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;COLOR&lt;/td&gt;&lt;td align="center"&gt;35.61&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;11.87&lt;/td&gt;&lt;td align="center"&gt;2.31&lt;/td&gt;&lt;td align="center"&gt;.093&lt;/td&gt;&lt;td align="center"&gt;.165&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Error&lt;/td&gt;&lt;td align="center"&gt;179.99&lt;/td&gt;&lt;td align="center"&gt;35&lt;/td&gt;&lt;td align="center"&gt;5.14&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Total&lt;/td&gt;&lt;td align="center"&gt;3143.34&lt;/td&gt;&lt;td align="center"&gt;40&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Total&lt;/td&gt;&lt;td align="center"&gt;443.71&lt;/td&gt;&lt;td align="center"&gt;39&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>24041</offset><text>Source	Type III Sum	df	Mean	F	Sig.	Eta2	 		of Squares		Square				 	Corrected Model	263.71	4	65.928	12.82	.000	.594	 	Intercept	185.62	1	185.62	36.09	.000	.508	 	VPADOSE	190.93	1	190.93	37.13	.000	.515	 	COLOR	35.61	3	11.87	2.31	.093	.165	 		 	Error	179.99	35	5.14				 		 	Total	3143.34	40					 		 	Corrected Total	443.71	39					 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>24372</offset><text>The 2-factor model (dose and color) presented in Table 11 are consistent with the conjecture that age and color demonstrate some interactive or synergistic effect, since color alone fails to attain significance.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>24584</offset><text>It is reasonable to surmise that the color effect for VPA is, at best, weak and mostly likely collinear with age. However, there is an effect for color that is operating as a stronger effect than discerned in the analysis of CBZ. This effect appears to be dependent on the stringency of the significance criteria used in the analysis, and the degree to which the analytic model disaggregates the hypothesized variable relationships. Selecting less conservative criteria will produce a weak, generalized significant color/assay relationship, but application of either more conservative methods to assess pair-relationships (e.g. Bonferroni criteria), or use of more elaborate model specifications (e.g., step-wise ANCOVA) fail to sustain significance. One of the more serious constraints on the VPA analysis presented here is the very limited number of persons with gray hair, and the number of light-haired persons in general (only 6 of the 40 subjects were not classified as either black or brown hair). A more confident analysis would require a sample with larger numbers</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_2</infon><offset>25658</offset><text>Phenytoin (PHT)</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>25674</offset><text>The PHT data set consists of 60 subjects (26 females, 34 males). The mean of age of this group is 35.85 years, s.d. 16.45 (median 35.0). Age skewness (.197) and kurtosis (-.844) are within normal bounds (skewness ratio = 0.64, kurtosis ratio = -.844). The mean length of time (duration) of the dose regimen for this group was 16.52 months (s.d. 8.88) with a range of from 2 to 24 months. The dosage values (in mg/day) ranged from 100 to 400 with a mean dose of 243.3 mg/day (s.d. 103.12, median 250). For both duration of regimen and daily dosage the skewness and kurtosis values are within normal range (&lt;2).</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>26284</offset><text>General Dose/Assay Relationship</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>26316</offset><text>The data for the dose assay relationship includes concentration in the plasma serum, which was determined by HPLC, and concentration in the hair, which was determined by both FPIA and HPLC. For hair assays the values are in micrograms per gram of hair, and for serum the values are in micrograms per milliliter of plasma.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>26638</offset><text>We note that, in contrast to both CBZ and VPA, Table 12 reveals that there is a significant bivariate dose/assay correlation for the serum specimens, and for the hair specimens by both analytic techniques.</text></passage><passage><infon key="file">T12.xml</infon><infon key="id">T12</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>26844</offset><text>Mean Concentration Values and Correlation Coefficients for Dose/Assay Relationship for Hair and Plasma, PHT</text></passage><passage><infon key="file">T12.xml</infon><infon key="id">T12</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;Specimen&lt;/td&gt;&lt;td align="center"&gt;PHT&lt;/td&gt;&lt;td align="center"&gt;HPLC Hair PHT&lt;/td&gt;&lt;td align="center"&gt;Correlation&lt;/td&gt;&lt;td align="center"&gt;FPIA Hair Mean&lt;/td&gt;&lt;td align="center"&gt;Correlation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Mean&lt;/td&gt;&lt;td align="center"&gt;Mean&lt;/td&gt;&lt;td align="center"&gt;Coefficient&lt;/td&gt;&lt;td align="center"&gt;PHT Concentration&lt;/td&gt;&lt;td align="center"&gt;Coefficient&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Dose&lt;/td&gt;&lt;td align="center"&gt;Concentration&lt;/td&gt;&lt;td align="center"&gt;(r)&lt;/td&gt;&lt;td align="center"&gt;[sd] (mcg/g)&lt;/td&gt;&lt;td align="center"&gt;(r)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;(mg/day)&lt;/td&gt;&lt;td align="center"&gt;[sd] (mcg/g)&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Hair&lt;/td&gt;&lt;td align="center"&gt;243.3&lt;/td&gt;&lt;td align="center"&gt;13.71 [7.32]&lt;/td&gt;&lt;td align="center"&gt;.882&lt;sup&gt;**&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;13.67 [7.20]&lt;/td&gt;&lt;td align="center"&gt;.883&lt;sup&gt;**&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Specimen&lt;/td&gt;&lt;td align="center"&gt;PHT&lt;/td&gt;&lt;td align="center"&gt;HPLC Serum&lt;/td&gt;&lt;td align="center"&gt;Correlation&lt;/td&gt;&lt;td align="center"&gt;FPIA Serum Mean&lt;/td&gt;&lt;td align="center"&gt;Correlation&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Mean&lt;/td&gt;&lt;td align="center"&gt;Mean PHT&lt;/td&gt;&lt;td align="center"&gt;Coefficient&lt;/td&gt;&lt;td align="center"&gt;PHT Concentration&lt;/td&gt;&lt;td align="center"&gt;Coefficient&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Dose&lt;/td&gt;&lt;td align="center"&gt;Concentration&lt;/td&gt;&lt;td align="center"&gt;(r)&lt;/td&gt;&lt;td align="center"&gt;[sd] (mcg/ml)&lt;/td&gt;&lt;td align="center"&gt;(r)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;(mg/day)&lt;/td&gt;&lt;td align="center"&gt;[sd] (mcg/ml)&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="6"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Serum&lt;/td&gt;&lt;td align="center"&gt;243.3&lt;/td&gt;&lt;td align="center"&gt;14.00 [3.40]&lt;/td&gt;&lt;td align="center"&gt;.779&lt;sup&gt;**&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;14.2 [3.50]&lt;/td&gt;&lt;td align="center"&gt;.743&lt;sup&gt;**&lt;/sup&gt;&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>26952</offset><text>Specimen	PHT	HPLC Hair PHT	Correlation	FPIA Hair Mean	Correlation	 		Mean	Mean	Coefficient	PHT Concentration	Coefficient	 		Dose	Concentration	(r)	[sd] (mcg/g)	(r)	 		(mg/day)	[sd] (mcg/g)				 	Hair	243.3	13.71 [7.32]	.882**	13.67 [7.20]	.883**	 		 	Specimen	PHT	HPLC Serum	Correlation	FPIA Serum Mean	Correlation	 		Mean	Mean PHT	Coefficient	PHT Concentration	Coefficient	 		Dose	Concentration	(r)	[sd] (mcg/ml)	(r)	 		(mg/day)	[sd] (mcg/ml)				 		 	Serum	243.3	14.00 [3.40]	.779**	14.2 [3.50]	.743**	 	</text></passage><passage><infon key="file">T12.xml</infon><infon key="id">T12</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>27457</offset><text>** significant @.01, two-tailed</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>27489</offset><text>Hair Color</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>27500</offset><text>Table 13 reports the number of subjects for each of four hair color categorizations, the mean concentration of PHT for that color category, and the related standard deviation. Visual examination of the table shows that both black and brown color had notably higher concentrations than either blond-haired or gray-haired subjects.</text></passage><passage><infon key="file">T13.xml</infon><infon key="id">T13</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>27830</offset><text>Mean Concentration of PHT by Hair Color</text></passage><passage><infon key="file">T13.xml</infon><infon key="id">T13</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;Hair Color&lt;/td&gt;&lt;td align="center"&gt;Number of&lt;/td&gt;&lt;td align="center"&gt;Mean PHT&lt;/td&gt;&lt;td align="center"&gt;Standard&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Subjects&lt;/td&gt;&lt;td align="center"&gt;Concentration&lt;/td&gt;&lt;td align="center"&gt;Deviation&lt;/td&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;24&lt;/td&gt;&lt;td align="center"&gt;16.35&lt;/td&gt;&lt;td align="center"&gt;5.79&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;18&lt;/td&gt;&lt;td align="center"&gt;16.76&lt;/td&gt;&lt;td align="center"&gt;7.68&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;8&lt;/td&gt;&lt;td align="center"&gt;7.92&lt;/td&gt;&lt;td align="center"&gt;2.92&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;10&lt;/td&gt;&lt;td align="center"&gt;6.55&lt;/td&gt;&lt;td align="center"&gt;4.82&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="4"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Overall Mean&lt;/td&gt;&lt;td align="center"&gt;60&lt;/td&gt;&lt;td align="center"&gt;13.71&lt;/td&gt;&lt;td align="center"&gt;7.32&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>27870</offset><text>Hair Color	Number of	Mean PHT	Standard	 		Subjects	Concentration	Deviation	 	Black	24	16.35	5.79	 	Brown	18	16.76	7.68	 	Blond	8	7.92	2.92	 	Gray	10	6.55	4.82	 		 	Overall Mean	60	13.71	7.32	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>28064</offset><text>A univariate ANOVA on the data in Table 13 reveal that there is a significant difference by hair color (F = 10.2, p = .000). However, the Levene Test indicates that the homogeneity of variance assumption is not met. An alternative analysis using Tamhane's procedure, allowing an assessment of unequal variances comparisons, also indicates significance, but allows for post-hoc contrasts for each specific color group. The individual comparisons are shown in Table 14.</text></passage><passage><infon key="file">T14.xml</infon><infon key="id">T14</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>28532</offset><text>Tamhane Post-Hoc Comparison of Color Groupings, PHT</text></passage><passage><infon key="file">T14.xml</infon><infon key="id">T14</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;Color Group&lt;/td&gt;&lt;td align="center"&gt;Significant?&lt;/td&gt;&lt;td align="center"&gt;p Value&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Contrast&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Black/Brown&lt;/td&gt;&lt;td align="center"&gt;No&lt;/td&gt;&lt;td align="center"&gt;1.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Black/Blond&lt;/td&gt;&lt;td align="center"&gt;Yes&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Black/Gray&lt;/td&gt;&lt;td align="center"&gt;Yes&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Brown/Blond&lt;/td&gt;&lt;td align="center"&gt;Yes&lt;/td&gt;&lt;td align="center"&gt;.002&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Brown/Gray&lt;/td&gt;&lt;td align="center"&gt;Yes&lt;/td&gt;&lt;td align="center"&gt;.001&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Blond/Gray&lt;/td&gt;&lt;td align="center"&gt;No&lt;/td&gt;&lt;td align="center"&gt;0.978&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>28584</offset><text>Color Group	Significant?	p Value	 	Contrast			 	Black/Brown	No	1.000	 	Black/Blond	Yes	.000	 	Black/Gray	Yes	.000	 	Brown/Blond	Yes	.002	 	Brown/Gray	Yes	.001	 	Blond/Gray	No	0.978	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>28768</offset><text>The ANOVA indicates that that there are significant differences in concentration of PHT by hair color. The overall mean concentration values appear to cluster, with the black/brown hair contrast showing no significant difference, and blond/gray contrast showing no significant difference. However, contrast of either blond or gray hair to black or brown hair does show significant difference. The overall distribution of PHT in the hair assays appears to meet the normality assumptions well.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">title_3</infon><offset>29260</offset><text>Hair Color/Dose Relationship</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>29289</offset><text>In order to further assess the nature of the hypothesized color effect, it is important to assess whether or not there is an interaction effect of color and dose. Is the effect a result of dosing values are higher for dark-haired subjects? Table 15 reports the relative frequency of daily dose regimens by hair color group.</text></passage><passage><infon key="file">T15.xml</infon><infon key="id">T15</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>29613</offset><text>Frequency Distribution of PHT Dosage by Hair Color</text></passage><passage><infon key="file">T15.xml</infon><infon key="id">T15</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;PHT&lt;/bold&gt;&lt;/td&gt;&lt;td align="center" colspan="4"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td colspan="4"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Dose&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;(mg/day)&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;100&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;6&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;200&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;6&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;300&lt;/td&gt;&lt;td align="center"&gt;12&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;td align="center"&gt;2&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;400&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;6&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;td align="center"&gt;0&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="5"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Total&lt;/td&gt;&lt;td align="center"&gt;24&lt;/td&gt;&lt;td align="center"&gt;18&lt;/td&gt;&lt;td align="center"&gt;8&lt;/td&gt;&lt;td align="center"&gt;10&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>29664</offset><text>PHT	Hair Color	 			 	Dose					 		Black	Brown	Blond	Gray	 	(mg/day)					 	100	4	2	2	6	 	200	4	6	4	2	 	300	12	4	2	2	 	400	4	6	0	0	 		 	Total	24	18	8	10	 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>29817</offset><text>Table 15 indicates that the higher dose values appear to cluster to some degree with black and brown-haired subjects. In order to assess this an ANCOVA model including dose, dose duration, age, and hair color is assessed. Results of that model are shown in Table 16.</text></passage><passage><infon key="file">T16.xml</infon><infon key="id">T16</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>30084</offset><text>General Linear Model, Analysis of Covariance, Hair Assay Outcome by Dose, Dose Duration, Age, and Hair Color, PHT</text></passage><passage><infon key="file">T16.xml</infon><infon key="id">T16</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;Source&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Type III Sum&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;df&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;F&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Sig.&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Eta&lt;sup&gt;2&lt;/sup&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;of Squares&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;Square&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Model&lt;/td&gt;&lt;td align="center"&gt;2750.79&lt;/td&gt;&lt;td align="center"&gt;6&lt;/td&gt;&lt;td align="center"&gt;458.46&lt;/td&gt;&lt;td align="center"&gt;59.70&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;td align="center"&gt;.871&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Intercept&lt;/td&gt;&lt;td align="center"&gt;78.61&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;78.61&lt;/td&gt;&lt;td align="center"&gt;10.24&lt;/td&gt;&lt;td align="center"&gt;.002&lt;/td&gt;&lt;td align="center"&gt;.162&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;AGE&lt;/td&gt;&lt;td align="center"&gt;48.64&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;48.64&lt;/td&gt;&lt;td align="center"&gt;6.34&lt;/td&gt;&lt;td align="center"&gt;.015&lt;/td&gt;&lt;td align="center"&gt;.107&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;DOSE&lt;/td&gt;&lt;td align="center"&gt;1593.67&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;1593.67&lt;/td&gt;&lt;td align="center"&gt;207.54&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;td align="center"&gt;.797&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;DOSEDUR&lt;/td&gt;&lt;td align="center"&gt;11.04&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;11.04&lt;/td&gt;&lt;td align="center"&gt;1.44&lt;/td&gt;&lt;td align="center"&gt;.236&lt;/td&gt;&lt;td align="center"&gt;.026&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;COLOR&lt;/td&gt;&lt;td align="center"&gt;227.13&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;75.71&lt;/td&gt;&lt;td align="center"&gt;9.86&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;td align="center"&gt;.358&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Error&lt;/td&gt;&lt;td align="center"&gt;406.98&lt;/td&gt;&lt;td align="center"&gt;53&lt;/td&gt;&lt;td align="center"&gt;7.68&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Total&lt;/td&gt;&lt;td align="center"&gt;14441.1&lt;/td&gt;&lt;td align="center"&gt;60&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Total&lt;/td&gt;&lt;td align="center"&gt;3157.77&lt;/td&gt;&lt;td align="center"&gt;59&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>30198</offset><text>Source	Type III Sum	df	Mean	F	Sig.	Eta2	 		of Squares		Square				 	Corrected Model	2750.79	6	458.46	59.70	.000	.871	 	Intercept	78.61	1	78.61	10.24	.002	.162	 	AGE	48.64	1	48.64	6.34	.015	.107	 	DOSE	1593.67	1	1593.67	207.54	.000	.797	 	DOSEDUR	11.04	1	11.04	1.44	.236	.026	 	COLOR	227.13	3	75.71	9.86	.000	.358	 		 	Error	406.98	53	7.68				 		 	Total	14441.1	60					 		 	Corrected Total	3157.77	59					 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>30604</offset><text>Table 16 indicates that age, dose, and color are significant factors in the model (values shaded gray are significant) while dose duration is not. This is identical to the model outcome for VPA. Table 17 shows the Bonferroni criteria for all pairwise combinations, their means differences, and their significance outcomes.</text></passage><passage><infon key="file">T17.xml</infon><infon key="id">T17</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>30927</offset><text>Pairwise Comparisons, Hair Color and Concentrations, PHT</text></passage><passage><infon key="file">T17.xml</infon><infon key="id">T17</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Std.&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Sig.&lt;sup&gt;a&lt;/sup&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;(I)&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;(J)&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Difference&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Error&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;(I-J)&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;.168&lt;/td&gt;&lt;td align="center"&gt;.865&lt;/td&gt;&lt;td align="center"&gt;1.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;3.287&lt;/td&gt;&lt;td align="center"&gt;1.245&lt;/td&gt;&lt;td align="center"&gt;.065&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;5.902&lt;sup&gt;*&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;1.265&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;-.168&lt;/td&gt;&lt;td align="center"&gt;.865&lt;/td&gt;&lt;td align="center"&gt;1.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;3.119&lt;/td&gt;&lt;td align="center"&gt;1.292&lt;/td&gt;&lt;td align="center"&gt;.116&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;5.734&lt;sup&gt;*&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;1.327&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;-3.287&lt;/td&gt;&lt;td align="center"&gt;1.245&lt;/td&gt;&lt;td align="center"&gt;.065&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;-3.119&lt;/td&gt;&lt;td align="center"&gt;1.292&lt;/td&gt;&lt;td align="center"&gt;.116&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;2.615&lt;/td&gt;&lt;td align="center"&gt;1.680&lt;/td&gt;&lt;td align="center"&gt;.754&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Gray&lt;/td&gt;&lt;td align="center"&gt;Black&lt;/td&gt;&lt;td align="center"&gt;-5.902&lt;sup&gt;*&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;1.265&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Brown&lt;/td&gt;&lt;td align="center"&gt;-5.732&lt;sup&gt;*&lt;/sup&gt;&lt;/td&gt;&lt;td align="center"&gt;1.327&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;Blond&lt;/td&gt;&lt;td align="center"&gt;-2.615&lt;/td&gt;&lt;td align="center"&gt;1.680&lt;/td&gt;&lt;td align="center"&gt;.754&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>30984</offset><text>Hair Color	Hair Color	Mean	Std.	Sig.a	 	(I)	(J)	Difference	Error		 			(I-J)			 	Black	Brown	.168	.865	1.000	 		Blond	3.287	1.245	.065	 		Gray	5.902*	1.265	.000	 	Brown	Black	-.168	.865	1.000	 		Blond	3.119	1.292	.116	 		Gray	5.734*	1.327	.000	 	Blond	Black	-3.287	1.245	.065	 		Brown	-3.119	1.292	.116	 		Gray	2.615	1.680	.754	 	Gray	Black	-5.902*	1.265	.000	 		Brown	-5.732*	1.327	.000	 		Blond	-2.615	1.680	.754	 	</text></passage><passage><infon key="file">T17.xml</infon><infon key="id">T17</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>31401</offset><text>a Bonferroni adjustment for multiple comparisons * mean difference is significant at he .05 level</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>31499</offset><text>As with VPA, the pairwise contrasts show that the black and gray and brown and gray contrasts are significant, while the remaining pairs do not have significant mean differences (the same results is obtained using Sidak criteria). It suggests, as with VPA, that there may be a color/age/dose confounding action involving either collinear or confounding relationships between hair color, dose, and age. In order to assess this we first consider the observed means and the estimates mean values from the ANCOVA model. This is presented in Table 18.</text></passage><passage><infon key="file">T18.xml</infon><infon key="id">T18</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>32046</offset><text>Mean Concentration Values and Model-Estimated Mean Values, PHT</text></passage><passage><infon key="file">T18.xml</infon><infon key="id">T18</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;Hair Color&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Estimated Means&lt;sup&gt;1&lt;/sup&gt;,&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;&lt;bold&gt;(N)&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Concentration&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;PHT (S.E.)&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;PHT (S.D.)&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="center"&gt;Black (24)&lt;/td&gt;&lt;td align="center"&gt;16.35 (5.79)&lt;/td&gt;&lt;td align="center"&gt;15.184 (0.58)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Brown (18)&lt;/td&gt;&lt;td align="center"&gt;16.76 (7.68)&lt;/td&gt;&lt;td align="center"&gt;15.02 (0.67)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Blond (8)&lt;/td&gt;&lt;td align="center"&gt;7.91 (2.92)&lt;/td&gt;&lt;td align="center"&gt;11.96 (1.11)&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="center"&gt;Gray (10)&lt;/td&gt;&lt;td align="center"&gt;6.55 (4.82)&lt;/td&gt;&lt;td align="center"&gt;9.23 (1.09)&lt;/td&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>32109</offset><text>Hair Color	Mean	Estimated Means1,	 	(N)	Concentration	PHT (S.E.)	 		PHT (S.D.)		 	Black (24)	16.35 (5.79)	15.184 (0.58)	 	Brown (18)	16.76 (7.68)	15.02 (0.67)	 	Blond (8)	7.91 (2.92)	11.96 (1.11)	 	Gray (10)	6.55 (4.82)	9.23 (1.09)	 	</text></passage><passage><infon key="file">T18.xml</infon><infon key="id">T18</infon><infon key="section_type">TABLE</infon><infon key="type">table_foot</infon><offset>32344</offset><text>1Evaluated at model covariates: PHT dose (mg/24hr) = 243.3, Age = 35.85</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>32416</offset><text>Table 18 reveals that the model-estimated means for dark hair (black and brown) are lower than the observed values, and the estimates for light colored hair are greater. This is a departure from the VPA pattern, and is consistent across category with a color/concentration positive relationship.</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>32712</offset><text>We can assess this effect by examining the ANCOVA model retaining dose and hair color as the sole covariates (replicating the procedure applied to VPA) and examining the surviving significant relationship. The results of this model are shown in Table 19.</text></passage><passage><infon key="file">T19.xml</infon><infon key="id">T19</infon><infon key="section_type">TABLE</infon><infon key="type">table_caption</infon><offset>32967</offset><text>General Linear Model, Analysis of Covariance, Hair Assay Outcome by Dose and Hair Color, PHT</text></passage><passage><infon key="file">T19.xml</infon><infon key="id">T19</infon><infon key="section_type">TABLE</infon><infon key="type">table</infon><infon key="xml">&lt;?xml version="1.0" encoding="UTF-8"?&gt;
&lt;table frame="hsides" rules="groups"&gt;&lt;thead&gt;&lt;tr&gt;&lt;td align="left"&gt;&lt;bold&gt;Source&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Type III Sum&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;df&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Mean&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;F&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Sig.&lt;/bold&gt;&lt;/td&gt;&lt;td align="center"&gt;&lt;bold&gt;Eta&lt;sup&gt;2&lt;/sup&gt;&lt;/bold&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;of Squares&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td align="center"&gt;&lt;bold&gt;Square&lt;/bold&gt;&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/thead&gt;&lt;tbody&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Model&lt;/td&gt;&lt;td align="center"&gt;2648.08&lt;/td&gt;&lt;td align="center"&gt;4&lt;/td&gt;&lt;td align="center"&gt;662.02&lt;/td&gt;&lt;td align="center"&gt;71.44&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;td align="center"&gt;.839&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Intercept&lt;/td&gt;&lt;td align="center"&gt;2.25&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;2.25&lt;/td&gt;&lt;td align="center"&gt;.243&lt;/td&gt;&lt;td align="center"&gt;.624&lt;/td&gt;&lt;td align="center"&gt;.004&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;DOSE&lt;/td&gt;&lt;td align="center"&gt;1532.31&lt;/td&gt;&lt;td align="center"&gt;1&lt;/td&gt;&lt;td align="center"&gt;1532.31&lt;/td&gt;&lt;td align="center"&gt;165.35&lt;/td&gt;&lt;td align="center"&gt;.000&lt;/td&gt;&lt;td align="center"&gt;.750&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;COLOR&lt;/td&gt;&lt;td align="center"&gt;191.68&lt;/td&gt;&lt;td align="center"&gt;3&lt;/td&gt;&lt;td align="center"&gt;63.89&lt;/td&gt;&lt;td align="center"&gt;6.895&lt;/td&gt;&lt;td align="center"&gt;.001&lt;/td&gt;&lt;td align="center"&gt;.273&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Error&lt;/td&gt;&lt;td align="center"&gt;509.69&lt;/td&gt;&lt;td align="center"&gt;55&lt;/td&gt;&lt;td align="center"&gt;9.27&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Total&lt;/td&gt;&lt;td align="center"&gt;14441.1&lt;/td&gt;&lt;td align="center"&gt;60&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td colspan="7"&gt;&lt;hr/&gt;&lt;/td&gt;&lt;/tr&gt;&lt;tr&gt;&lt;td align="left"&gt;Corrected Total&lt;/td&gt;&lt;td align="center"&gt;3157.77&lt;/td&gt;&lt;td align="center"&gt;59&lt;/td&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;td/&gt;&lt;/tr&gt;&lt;/tbody&gt;&lt;/table&gt;
</infon><offset>33060</offset><text>Source	Type III Sum	df	Mean	F	Sig.	Eta2	 		of Squares		Square				 	Corrected Model	2648.08	4	662.02	71.44	.000	.839	 	Intercept	2.25	1	2.25	.243	.624	.004	 	DOSE	1532.31	1	1532.31	165.35	.000	.750	 	COLOR	191.68	3	63.89	6.895	.001	.273	 		 	Error	509.69	55	9.27				 		 	Total	14441.1	60					 		 	Corrected Total	3157.77	59					 	</text></passage><passage><infon key="section_type">RESULTS</infon><infon key="type">paragraph</infon><offset>33390</offset><text>Consistent with the approach applied to VPA, we delete age from the model in Table 19. Age is removed from the model in this case to see if it diminishes the color effect, as was the case VPA. Comparison of Tables 17 and 18 show that the eta2 is diminished, but is still significant and makes a substantial contribution to the explained variance. Dose still has, however, the higher eta2 value. Further pairwise comparisons show that there are significant mean value contrasts between the light hair categories (gray and blond) and the dark hair categories (black and brown). There are, however, no significant contrasts within those groups (i.e., no significant mean differences between black and brown hair or blond and gray hair).</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">title_1</infon><offset>34124</offset><text>Remarkable conclusions</text></passage><passage><infon key="section_type">CONCL</infon><infon key="type">paragraph</infon><offset>34136</offset><text>The assessment of the recovery of CBZ, VPA, and PHT compounds from hair samples indicates that hair color affects drug type significantly, with some effects only slightly different.</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>35314</offset><text>Pre-publication history</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">paragraph</infon><offset>35338</offset><text>The pre-publication history for this paper can be accessed here:</text></passage><passage><infon key="section_type">SUPPL</infon><infon key="type">title_1</infon><offset>35403</offset><text>Supplementary Material</text></passage><passage><infon key="fpage">A3</infon><infon key="name_0">surname:Baumgartner;given-names:WA</infon><infon key="section_type">REF</infon><infon key="source">Clin Nucl Med</infon><infon key="type">ref</infon><infon key="volume">10</infon><infon key="year">1985</infon><offset>35426</offset><text>Detection of drug use by (RIA) of hair.</text></passage><passage><infon key="fpage">65</infon><infon key="lpage">78</infon><infon key="name_0">surname:Schutz;given-names:H</infon><infon key="pub-id_pmid">8316574</infon><infon key="section_type">REF</infon><infon key="source">Pharm Unserer Zeit</infon><infon key="type">ref</infon><infon key="volume">22</infon><infon key="year">1993</infon><offset>35466</offset><text>The detection of drugs and other foreign substances in hair.</text></passage><passage><infon key="name_0">surname:Chatt;given-names:A</infon><infon key="name_1">surname:Katz;given-names:S</infon><infon key="section_type">REF</infon><infon key="source">New York: VCH Publishers,</infon><infon key="type">ref</infon><infon key="year">1988</infon><offset>35527</offset><text>Hair Analysis: Applications in the Biomedical and Environmental Sciences.</text></passage><passage><infon key="fpage">797</infon><infon key="name_0">surname:Arnold;given-names:W</infon><infon key="section_type">REF</infon><infon key="source">J Clin Chem Clin Biochem</infon><infon key="type">ref</infon><infon key="volume">24</infon><infon key="year">1986</infon><offset>35601</offset><text>RIA analysis of head hair for narcotics and substitutes.</text></passage><passage><infon key="fpage">569</infon><infon key="lpage">573</infon><infon key="name_0">surname:Koren;given-names:G</infon><infon key="section_type">REF</infon><infon key="source">Sunshine, I. ed. Recent Developments in Therapeutic Drug Monitoring in Clinical Toxicology, New York : Marcel Dekker,</infon><infon key="type">ref</infon><infon key="year">1992</infon><offset>35658</offset><text>Hair tests to verify gestational cocaine exposure.</text></passage><passage><infon key="fpage">132</infon><infon key="lpage">150</infon><infon key="name_0">surname:Mieczkowski;given-names:T</infon><infon key="section_type">REF</infon><infon key="source">Ann Am Acad Pol &amp; Soc Sci</infon><infon key="type">ref</infon><infon key="volume">521</infon><infon key="year">1992</infon><offset>35709</offset><text>New approaches in drug testing: A review of hair analysis.</text></passage><passage><infon key="fpage">72</infon><infon key="lpage">76</infon><infon key="name_0">surname:Kintz;given-names:P</infon><infon key="pub-id_pmid">1545215</infon><infon key="section_type">REF</infon><infon key="source">J Forensic Sci</infon><infon key="type">ref</infon><infon key="volume">37</infon><infon key="year">1992</infon><offset>35768</offset><text>Evaluation of nicotine and cotinine in human hair.</text></passage><passage><infon key="fpage">118</infon><infon key="lpage">126</infon><infon key="name_0">surname:Balabanova;given-names:S</infon><infon key="section_type">REF</infon><infon key="source">Scientific Symposium Rechtsmedizin und Forensiche Toxikologie, Hamburg,</infon><infon key="type">ref</infon><infon key="year">1990</infon><offset>35819</offset><text>Detection of caffeine in human hair by EIA and GC/MS Proceedings.</text></passage><passage><infon key="fpage">686</infon><infon key="lpage">691</infon><infon key="name_0">surname:Sato;given-names:R</infon><infon key="pub-id_pmid">2595750</infon><infon key="section_type">REF</infon><infon key="source">Ther Drug Monit</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1989</infon><offset>35885</offset><text>Human scalp hair as evidence of individual dosage history of haloperidol: Prospective study.</text></passage><passage><infon key="fpage">187</infon><infon key="lpage">194</infon><infon key="name_0">surname:Matsuno;given-names:H</infon><infon key="pub-id_pmid">2306410</infon><infon key="section_type">REF</infon><infon key="source">Br J Clin Pharmacol</infon><infon key="type">ref</infon><infon key="volume">29</infon><infon key="year">1990</infon><offset>35978</offset><text>The measurement of haloperidol and reduced haloperidol in hair as an index of dosage history.</text></passage><passage><infon key="fpage">355</infon><infon key="lpage">357</infon><infon key="name_0">surname:Runne;given-names:U</infon><infon key="section_type">REF</infon><infon key="source">Acta Dermato-Venereolog</infon><infon key="type">ref</infon><infon key="volume">72</infon><infon key="year">1992</infon><offset>36072</offset><text>Sequential concentration of chloroquine in human hair correlates with ingested dose and duration of therapy.</text></passage><passage><infon key="fpage">363</infon><infon key="lpage">367</infon><infon key="name_0">surname:Tracqui;given-names:A</infon><infon key="section_type">REF</infon><infon key="source">Hum Exp Tox</infon><infon key="type">ref</infon><infon key="volume">11</infon><infon key="year">1992</infon><offset>36181</offset><text>Determination of amitriptyline in the hair of psychiatric patients.</text></passage><passage><infon key="fpage">65</infon><infon key="lpage">77</infon><infon key="name_0">surname:Miyazawa;given-names:N</infon><infon key="pub-id_doi">10.1016/0379-0738(91)90206-X</infon><infon key="pub-id_pmid">1752595</infon><infon key="section_type">REF</infon><infon key="source">Forensic Sci Int</infon><infon key="type">ref</infon><infon key="volume">51</infon><infon key="year">1991</infon><offset>36249</offset><text>Ofloxacin in human hair determined by HPLC.</text></passage><passage><infon key="fpage">45</infon><infon key="lpage">48</infon><infon key="name_0">surname:Uematsu;given-names:T</infon><infon key="section_type">REF</infon><infon key="source">J Pharmaceut Sci</infon><infon key="type">ref</infon><infon key="volume">81</infon><infon key="year">1992</infon><offset>36293</offset><text>Possible effect of pigment on the pharmacokinetics of ofloxacin and its excretion in hair.</text></passage><passage><infon key="fpage">199</infon><infon key="lpage">203</infon><infon key="name_0">surname:Uematsu;given-names:T</infon><infon key="pub-id_pmid">8382934</infon><infon key="section_type">REF</infon><infon key="source">Br J Clin Pharmacol</infon><infon key="type">ref</infon><infon key="volume">35</infon><infon key="year">1993</infon><offset>36384</offset><text>The measurement of a new antimicrobial quinolone in hair as an index of drug exposure.</text></passage><passage><infon key="fpage">187</infon><infon key="lpage">193</infon><infon key="name_0">surname:Mizuno;given-names:A</infon><infon key="pub-id_doi">10.1016/0378-4347(93)E0440-2</infon><infon key="section_type">REF</infon><infon key="source">J Chromatogr B</infon><infon key="type">ref</infon><infon key="volume">653</infon><infon key="year">1994</infon><offset>36471</offset><text>Simultaneous determination of ofloxacin, norfloxacin and ciprofloxacin in human hair by HPLC and fluorescence detection.</text></passage><passage><infon key="fpage">59</infon><infon key="lpage">73</infon><infon key="name_0">surname:Cirimele;given-names:V</infon><infon key="pub-id_pmid">10216985</infon><infon key="section_type">REF</infon><infon key="source">Acta Clinica Belgica</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">1999</infon><offset>36592</offset><text>Evidence of pesticide exposure by hair analysis.</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">3</infon><infon key="name_0">surname:Deveaux;given-names:M</infon><infon key="section_type">REF</infon><infon key="source">p 219-223 For Sci Int</infon><infon key="type">ref</infon><infon key="volume">84</infon><infon key="year">1997</infon><offset>36641</offset><text>Immunoassay of digoxin in hair.</text></passage><passage><infon key="fpage">5</infon><infon key="lpage">8</infon><infon key="name_0">surname:Wheeler;given-names:MJ</infon><infon key="section_type">REF</infon><infon key="source">J Endocrinol</infon><infon key="type">ref</infon><infon key="volume">159</infon><infon key="year">1998</infon><offset>36673</offset><text>The measurement of testosterone in hair.</text></passage><passage><infon key="fpage">343</infon><infon key="lpage">346</infon><infon key="name_0">surname:Deng</infon><infon key="pub-id_pmid">10097359</infon><infon key="section_type">REF</infon><infon key="source">J Forensic Sci</infon><infon key="type">ref</infon><infon key="volume">44</infon><infon key="year">1999</infon><offset>36714</offset><text>Detection of anabolic steroids in hair</text></passage><passage><infon key="fpage">443</infon><infon key="lpage">466</infon><infon key="name_0">surname:Williams;given-names:J</infon><infon key="section_type">REF</infon><infon key="source">deZeeuw, R., Munthiri, S., el Hosani, B. eds. Proceedings of the International Conference and Workshop for Hair Analysis in Forensic Toxicology, Abu Dhabi, UAE</infon><infon key="type">ref</infon><infon key="year">1995</infon><offset>36753</offset><text>Sectional hair analysis as a potential index of therapeutic compliance in an epileptic population</text></passage><passage><infon key="fpage">1</infon><infon key="lpage">32</infon><infon key="name_0">surname:Williams;given-names:J</infon><infon key="section_type">REF</infon><infon key="source">Mieczkowski, T. ed. Drug Testing Technology-Assessment of Field Applications, Boca Raton, Florida, CRC Press,</infon><infon key="type">ref</infon><infon key="year">1999</infon><offset>36851</offset><text>The assessment of therapeutic compliance based on the analysis of drug concentrations in hair.</text></passage><passage><infon key="fpage">812</infon><infon key="lpage">815</infon><infon key="name_0">surname:Kintz;given-names:P</infon><infon key="section_type">REF</infon><infon key="source">Human Exper Toxicol</infon><infon key="type">ref</infon><infon key="volume">14</infon><infon key="year">1995</infon><offset>36946</offset><text>Testing hair for carbamazepine in epileptic patients: Is hair investigation suitable for drug monitoring?</text></passage><passage><infon key="fpage">92</infon><infon key="lpage">94</infon><infon key="name_0">surname:Mei;given-names:Z</infon><infon key="pub-id_doi">10.1097/00007691-199702000-00017</infon><infon key="pub-id_pmid">9029755</infon><infon key="section_type">REF</infon><infon key="source">Ther Drug Monit</infon><infon key="type">ref</infon><infon key="volume">1</infon><infon key="year">1997</infon><offset>37052</offset><text>Simultaneous determination of phenytoin and carbamazepine in human hair by HPLC.</text></passage><passage><infon key="fpage">409</infon><infon key="lpage">415</infon><infon key="name_0">surname:Saris;given-names:L</infon><infon key="pub-id_doi">10.1016/S0378-4347(96)00450-1</infon><infon key="section_type">REF</infon><infon key="source">J Chromatogr B Biomed Appi</infon><infon key="type">ref</infon><infon key="volume">691</infon><infon key="year">1997</infon><offset>37133</offset><text>HPLC determination of carbamazepine and metabolites in human hair.</text></passage><passage><infon key="fpage">187</infon><infon key="lpage">195</infon><infon key="name_0">surname:Tsatsakis;given-names:AM</infon><infon key="pub-id_doi">10.1016/S0009-8981(97)00057-0</infon><infon key="section_type">REF</infon><infon key="source">Clinica Chimica Acta</infon><infon key="type">ref</infon><infon key="volume">263</infon><infon key="year">1997</infon><offset>37200</offset><text>Carbamazepine levels in the hair of patients under long-term treatment: a preliminary study.</text></passage><passage><infon key="fpage">459</infon><infon key="lpage">466</infon><infon key="name_0">surname:Tsatsakis;given-names:AM</infon><infon key="section_type">REF</infon><infon key="source">Bolletino Chimico Farmaceutico</infon><infon key="type">ref</infon><infon key="volume">137</infon><infon key="year">1998</infon><offset>37293</offset><text>Determination of phenytoin in sections of head hair: a preliminary study to evaluate the history of drug use.</text></passage><passage><infon key="fpage">55</infon><infon key="lpage">67</infon><infon key="name_0">surname:Psillakis;given-names:T</infon><infon key="pub-id_doi">10.1177/00912709922007561</infon><infon key="pub-id_pmid">9987701</infon><infon key="section_type">REF</infon><infon key="source">J Clin Pharmacol</infon><infon key="type">ref</infon><infon key="volume">39</infon><infon key="year">1999</infon><offset>37403</offset><text>Carbamazepine levels in head hair of patients under long-term treatment: A method to evaluate the history of drug use.</text></passage><passage><infon key="fpage">43</infon><infon key="name_0">surname:Tsatsakis;given-names:AM</infon><infon key="name_1">surname:Psilakis;given-names:TK</infon><infon key="name_2">surname:Alegakis;given-names:Th.K</infon><infon key="name_3">surname:Tzatzarakis;given-names:M</infon><infon key="section_type">REF</infon><infon key="source">34th Intern Proceedings, Congress Forensic Toxicology, TIAFT, Interlaken, Switzerland</infon><infon key="type">ref</infon><infon key="year">1996</infon><offset>37522</offset><text>Determination of carbamazepine and valproic acid in human head hair.</text></passage><passage><infon key="fpage">183</infon><infon key="lpage">189</infon><infon key="name_0">surname:Tracqui;given-names:A</infon><infon key="name_1">surname:Kintz;given-names:P</infon><infon key="name_2">surname:Mangin;given-names:P</infon><infon key="pub-id_doi">10.1016/0379-0738(94)01626-G</infon><infon key="section_type">REF</infon><infon key="source">For Sci Int</infon><infon key="type">ref</infon><infon key="volume">70</infon><infon key="year">1995</infon><offset>37591</offset><text>Hair analysis: A worthless tool for therapeutic compliance monitoring.</text></passage><passage><infon key="name_0">surname:Mieczkowski;given-names:T</infon><infon key="section_type">REF</infon><infon key="source">Assessment of Field Applications, Boca Raton, Florida, CRC Press,</infon><infon key="type">ref</infon><infon key="year">1999</infon><offset>37662</offset><text>Drug Testing Technology.</text></passage><passage><infon key="fpage">39</infon><infon key="lpage">43</infon><infon key="name_0">surname:Mieczkowski;given-names:T</infon><infon key="pub-id_doi">10.1016/S0024-3205(00)00601-9</infon><infon key="pub-id_pmid">10896027</infon><infon key="section_type">REF</infon><infon key="source">Life Sci</infon><infon key="type">ref</infon><infon key="volume">671</infon><infon key="year">2000</infon><offset>37687</offset><text>Is a color effect demonstrated for hair analysis of carbamazepine?</text></passage></document></collection>